🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Agilent shares target cut by BofA on FY guide concerns

EditorEmilio Ghigini
Published 05/30/2024, 06:40 PM
A
-

On Thursday, BofA Securities adjusted its outlook on Agilent Technologies, Inc. (NYSE:A) shares, reducing the price target to $134 from the previous $145, while maintaining a Neutral rating on the stock.

The revision follows the company's financial guidance update, which revealed a more substantial reduction in its full-year forecast than was widely anticipated by the market.

The management at Agilent underscored a year-over-year order growth in the second fiscal quarter, marking the first instance of such growth in seven quarters. This included growth in instrument orders outside of China.

However, the reduction in the price target was attributed to the fact that order acceleration did not meet management's earlier expectations, making a second-half fiscal year rebound seem improbable.

The analyst noted that while Agilent's management had anticipated a more significant increase in orders, other vendors in the Tools sector did not share this expectation, and thus the positive commentary on order growth should be received favorably by the market.

Furthermore, the areas where Agilent experienced weakness, such as NASD, pharmaceutical instrumentation, and the timing of China's fiscal year-end stimulus, appear to be specific to Agilent rather than indicative of a broader sector issue.

As a result, the firm's stance on the Tools group and other companies within the sector, like Thermo Fisher Scientific (NYSE:NYSE:TMO) and Danaher Corporation (NYSE:NYSE:DHR), remains unchanged despite Agilent's revised forecast.

The price target adjustment reflects a cautious outlook on Agilent's financial performance for the remainder of the fiscal year.

InvestingPro Insights

Following BofA Securities' revised price target for Agilent Technologies, Inc., InvestingPro data and tips offer additional context for investors weighing their options. Agilent's market cap stands at a robust $42.63 billion, and with a P/E ratio of 34.49, it trades at a high earnings multiple relative to its earnings. Despite a slight revenue decline of 2.81% over the last twelve months as of Q1 2024, the company maintains a strong gross profit margin of 50.56%, showcasing efficiency in its operations.

Investors might also appreciate the stability that Agilent presents, as evidenced by its 13-year streak of consistent dividend payments, a testament to its financial reliability. Moreover, the company's dividend yield currently sits at 0.65%, with a recent growth of 4.89% in dividends. The InvestingPro Tips highlight that Agilent's liquid assets exceed its short-term obligations and that it operates with a moderate level of debt, indicating a solid financial footing.

For those interested in a deeper dive, InvestingPro offers additional insights and metrics on Agilent Technologies, which can be accessed with a special offer. Use the coupon code PRONEWS24 to get an extra 10% off a yearly or biyearly Pro and Pro+ subscription. There are 10 more InvestingPro Tips available for Agilent, providing a comprehensive view of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.